The aim of this study is to explore the association between irisin, histological features and biomarkers of liver fibrogenesis in non-diabetic, non-obese, biopsy-proven NAFLD individuals. The gene discussed is FNDC5; the disease is metabolic dysfunction-associated steatotic liver disease.